Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma

Ai zheng = Aizheng = Chinese journal of cancer

Volumn 24, Issue 12, 2005, Pages 1498-1502

  Wu, Hong Ju ^a   Zhang, Qing Yuan ^a   Chen, De Fa ^a   Guan, Xiao Jun ^a   Zhang, Bo Long ^a   Ma, Jun ^a  

^a Harbin Institute of Hematology and Oncology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN; CHOP PROTOCOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; MONOCLONAL ANTIBODY; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOLOGY; LARGE CELL LYMPHOMA; LEUKOPENIA; MALE; PROSPECTIVE STUDY; REMISSION; SURVIVAL RATE;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LEUKOPENIA; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; PREDNISONE; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL RATE; VINCRISTINE;

EID: 34547297482     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)